Crossmark

Human germline genome editing is illegal in Canada, but could it be desirable for some members of the rare disease community?

Published Online: 2019-08-16

Published Print: 2020-04

Authors

Kleiderman, Erika https://orcid.org/0000-0002-0242-2296
Stedman, Ian Norris Kellner
License Information

Text and Data Mining valid from 2019-08-16

Version of Record valid from 2019-08-16
More Information

Article History

Received: 6 August 2018

Accepted: 7 July 2019

First Online: 16 August 2019

Compliance with ethics standards

:

: Erika Kleiderman declares that she has no conflict of interest.Ian Stedman is a former member of the Board of Directors of the Canadian Organization for Rare Disorders and a member of the Working Group on Rare Disease Research (Rare Disease International).

: This article does not contain any studies with human participants or animals performed by any of the authors.

Document is current